A trial found better QoL and improved dysbiosis.

Takeaway

• Among young children with chronic rhinosinusitis (CRS), treatment with intranasal corticosteroids (INCs) led to higher QoL and a more diverse sinonasal microbiome.

• This lends weight to the recommendation to...